This investigation shows anti-inflammatory effects in monocytes from women with preeclampsia, suggesting a new therapeutic avenue.
These findings support its potential as an adjunctive therapy to modulate the inflammatory profile in women with preeclampsia, particularly in those with EOPE disease.
No takes yet. Share an insight, caveat, or question.
Ribeiro-Vasques et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: